Adults with mild to severe obstructive sleep apnea achieved lower disease severity with AD109, an oral combination drug, at ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

Testosterone is being hailed as the secret to better energy, mood, and sex drive. Here’s what experts say about when it ...

Open-label or ‘honest’ placebos are linked to reduced pain-related disability and may have a supportive role in migraine care ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

Experts say there are some components of the cannabis plant “that appear to be helpful for some people with regard to sleep." ...

A new study suggests that low-dose radiation therapy could fill the treatment gap between pain medications and joint ...

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with ...

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant ...

Millions of Americans use weed to treat chronic pain, but there's little high quality research on whether it works. New ...

For too long in the Western world, ageing has been perceived as something negative, especially for women. The message we ...

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.